HOYA Co. (OTCMKTS:HOCPY – Get Rating) was the recipient of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 800 shares, a drop of 97.2% from the March 15th total of 28,600 shares. Based on an average daily trading volume, of 101,800 shares, the short-interest ratio is presently 0.0 days.
Separately, Zacks Investment Research raised HOYA from a “hold” rating to a “buy” rating and set a $127.00 price target on the stock in a research note on Monday.
OTCMKTS HOCPY traded down $4.32 during trading hours on Wednesday, hitting $101.65. The company’s stock had a trading volume of 66,506 shares, compared to its average volume of 45,799. HOYA has a twelve month low of $101.58 and a twelve month high of $179.94. The firm has a market capitalization of $37.58 billion, a P/E ratio of 26.47, a PEG ratio of 1.33 and a beta of 0.41. The company has a quick ratio of 4.28, a current ratio of 4.89 and a debt-to-equity ratio of 0.02. The stock has a fifty day moving average of $121.60 and a 200 day moving average of $139.68.
HOYA Company Profile (Get Rating)
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company operates through three segments: Life Care, Information Technology, and Other. The Life Care segment offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endoscopes, laparoscopic surgical instruments, intraocular lenses, and prosthetic ceramic fillers and orthopedic implants.
- Get a free copy of the StockNews.com research report on HOYA (HOCPY)
- OrganiGram’s Turnaround Begins To Blossom
- Three Dividend Stocks With Growth Potential
- Exelon Stock Still Has Extraordinary Upside
- Greenbrier Companies Stock has Green in its Future
- Insiders Are Selling Palo Alto Networks
Receive News & Ratings for HOYA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HOYA and related companies with MarketBeat.com's FREE daily email newsletter.